{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:30:58Z","timestamp":1772177458183,"version":"3.50.1"},"reference-count":37,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1590\/s0100-879x2004000500004","type":"journal-article","created":{"date-parts":[[2005,4,13]],"date-time":"2005-04-13T16:50:11Z","timestamp":1113411011000},"page":"649-658","source":"Crossref","is-referenced-by-count":17,"title":["An improved HPLC method for the quantitation of 6-mercaptopurine and its metabolites in red blood cells"],"prefix":"10.1590","volume":"37","author":[{"given":"B.M.","family":"Oliveira","sequence":"first","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Romanha","sequence":"additional","affiliation":[{"name":"FIOCRUZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.M.A.","family":"Alves","sequence":"additional","affiliation":[{"name":"FIOCRUZ, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.B.","family":"Viana","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.L.","family":"Zani","sequence":"additional","affiliation":[{"name":"FIOCRUZ, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/sj.leu.2402065","article-title":"The treatment of acute leukemia: past, present, and future","volume":"15","author":"Beutler E","year":"2001","journal-title":"Leukemia","ISSN":"https:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/adc.82.6.438","article-title":"Recent advances in management of acute leukemia","volume":"82","author":"Chessels JM","year":"2000","journal-title":"Archives of Disease in Childhood","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9888","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1200\/JCO.1996.14.1.4","article-title":"Selecting treatment for children with acute lymphoblastic leukemia","volume":"14","author":"Pinkel D","year":"1996","journal-title":"Journal of Clinical Oncology","ISSN":"https:\/\/id.crossref.org\/issn\/0732-183X","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0140-6736(93)91951-H","article-title":"Non-compliance - or how many aunts has Matilda?","volume":"342","author":"Wright EC","year":"1993","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0378-4347(00)83147-3","article-title":"Rapid method for evaluating compliance of 6-mercaptopurine therapy in children with leukemia","volume":"430","author":"Azeemuddin S","year":"1998","journal-title":"Journal of Chromatography","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9673","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00007691-199210000-00005","article-title":"Pattern of 6-mercaptopurine urinary excretion in children with acute lymphoblastic leukemia: urinary assays as a measure of drug compliance","volume":"14","author":"MacDougall LG","year":"1992","journal-title":"Therapeutic Drug Monitoring","ISSN":"https:\/\/id.crossref.org\/issn\/0163-4356","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/bmj.306.6887.1239","article-title":"Variable mercaptopurine metabolism in children with leukaemia: a problem of non-compliance","volume":"306","author":"Davies HA","year":"1993","journal-title":"British Medical Journal","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1447","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/bjc.1995.450","article-title":"Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance?","volume":"72","author":"Lennard L","year":"1995","journal-title":"British Journal of Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0007-0920","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/adc.76.4.365","article-title":"Profile of non-compliance in lymphoblastic leukaemia","volume":"76","author":"Lancaster D","year":"1997","journal-title":"Archives of Disease in Childhood","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9888","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF02220605","article-title":"The clinical pharmacology of 6-mercaptopurine","volume":"43","author":"Lennard L","year":"1992","journal-title":"European Journal of Clinical Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0031-6970","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00007691-199608000-00003","article-title":"Individualizing therapy with 6-mercaptopurine and 6-thioguanine related to the thiopurine methyltransferase genetic polymorphism","volume":"18","author":"Lennard L","year":"1996","journal-title":"Therapeutic Drug Monitoring","ISSN":"https:\/\/id.crossref.org\/issn\/0163-4356","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1365-2141.1999.01416.x","article-title":"Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia","volume":"105","author":"McLeod HL","year":"1999","journal-title":"British Journal of Haematology","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1048","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0306-3623(99)00022-1","article-title":"The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX)","volume":"33","author":"Giverhaug T","year":"1999","journal-title":"General Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0306-3623","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/clpt.1987.4","article-title":"Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations","volume":"41","author":"Lennard L","year":"1987","journal-title":"Clinical Pharmacology and Therapeutics","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9236","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0140-6736(90)91745-V","article-title":"Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia","volume":"336","author":"Lennard L","year":"1990","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/clpt.1994.4","article-title":"Thiopurine methyltransferase activity in American white subjects and black subjects","volume":"55","author":"McLeod HL","year":"1994","journal-title":"Clinical Pharmacology and Therapeutics","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9236","issn-type":"print"},{"key":"ref17","first-page":"651","article-title":"Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity","volume":"32","author":"Weinshilboum RM","year":"1980","journal-title":"American Journal of Human Genetics","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9297","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2125.1995.tb05776.x","article-title":"The accumulation of mercaptopurine metabolites in age fractionated red blood cells","volume":"40","author":"Rostami-Hodjegan A","year":"1980","journal-title":"British Journal of Clinical Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0264-3774","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00043426-199302000-00010","article-title":"Cellular pharmacology of 6-mercaptopurine in acute lymphoblastic leukemia","volume":"15","author":"Bostrom B","year":"1993","journal-title":"American Journal of Pediatric Hematology\/Oncology","ISSN":"https:\/\/id.crossref.org\/issn\/0192-8562","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood.V92.10.3569","article-title":"Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: A joint children's cancer group and pediatric oncology branch study","volume":"92","author":"Balis FM","year":"1998","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF02897232","article-title":"6-Thioguanine nucleotide accumulation in red blood cells during maintenance chemotherapy for childhood acute lymphoblastic leukemia, and it relation to leukopenia","volume":"26","author":"Schmiegelow K","year":"1998","journal-title":"Cancer Chemotherapy and Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0344-5704","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/adc.69.5.577","article-title":"Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia","volume":"69","author":"Lennard L","year":"1993","journal-title":"Archives of Disease in Childhood","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9888","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1200\/JCO.1995.13.2.345","article-title":"Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance therapy","volume":"13","author":"Schmiegelow K","year":"1995","journal-title":"Journal of Clinical Oncology","ISSN":"https:\/\/id.crossref.org\/issn\/0732-183X","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00007691-200008000-00002","article-title":"Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity: Implications for drug monitoring in children with acute lymphoblastic leukemia","volume":"22","author":"Innocenti F","year":"2000","journal-title":"Therapeutic Drug Monitoring","ISSN":"https:\/\/id.crossref.org\/issn\/0163-4356","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/clinchem\/44.12.2511","article-title":"Identification of 6- methylmercaptopurine derivative formed during acid hydrolysis of thiopurine nucleotides in erythrocytes, using liquid chromatography-mass spectrometry, infrared spectroscopy, and nuclear magnetic resonance assay","volume":"44","author":"Dervieux T","year":"1998","journal-title":"Clinical Chemistry","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9147","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0378-4347(92)80347-S","article-title":"High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantification of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample","volume":"583","author":"Lennard L","year":"1992","journal-title":"Journal of Chromatography","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9673","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/clinchem\/44.3.551","article-title":"Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC","volume":"44","author":"Dervieux T","year":"1998","journal-title":"Clinical Chemistry","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9147","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0378-4347(87)80340-7","article-title":"Assay of 6-thioinosinic acid and 6-thioguanine nucleotides, active metabolites of 6-mercaptopurine, in human red blood cells","volume":"423","author":"Lennard L","year":"1987","journal-title":"Journal of Chromatography","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9673","issn-type":"print"},{"key":"ref29","article-title":"Clinical and laboratory evaluation of compliance in acute lymphoblastic leukaemia","author":"Oliveira BM","year":"2004","journal-title":"Archives of Disease in Childhood","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9888","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00007691-199105000-00006","article-title":"Determination of 6-mercaptopurine in acute lymphoblastic leukemia patients' plasma by high performance liquid chromatography","volume":"13","author":"Kato Y","year":"1991","journal-title":"Therapeutic Drug Monitoring","ISSN":"https:\/\/id.crossref.org\/issn\/0163-4356","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1177\/000456328802500505","article-title":"HPLC analysis of 6-mercaptopurine and metabolites in extracellular body fluids","volume":"25","author":"Rudy JL","year":"1988","journal-title":"Annals of Clinical Biochemistry","ISSN":"https:\/\/id.crossref.org\/issn\/0004-5632","issn-type":"print"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0305-7372(95)90022-5","article-title":"Compliance with oral chemotherapy in childhood lymphoblastic leukaemia","volume":"21","author":"Davies HA","year":"1995","journal-title":"Cancer Treatment Reviews","ISSN":"https:\/\/id.crossref.org\/issn\/0305-7372","issn-type":"print"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00007691-199712000-00010","article-title":"Analysis of methylated 6-mercaptopurine metabolites in human red blood cells: Comparison of two methods","volume":"19","author":"Giverhaug T","year":"1997","journal-title":"Therapeutic Drug Monitoring","ISSN":"https:\/\/id.crossref.org\/issn\/0163-4356","issn-type":"print"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0378-4347(98)00329-6","article-title":"Reversed-phase high-perfomance liquid chromatographic assay method for quantitating 6-mercaptopurine and its methylated and non-methylated metabolites in a single sample","volume":"716","author":"Mawatari H","year":"1998","journal-title":"Journal of Chromatography","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9673","issn-type":"print"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/bmc.1130040202","article-title":"A reversed phase high performance liquid chromatography approach in determining total red blood cell concentrations of 6-thioguanine, 6-mercaptopurine, methylthioguanine, and methylmercaptopurine in patient receiving thiopurine therapy","volume":"4","author":"Erdmann GR","year":"1990","journal-title":"Biomedical Chromatography","ISSN":"https:\/\/id.crossref.org\/issn\/0269-3879","issn-type":"print"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/jnci\/91.23.2001","article-title":"Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus","volume":"91","author":"Relling MV","year":"1999","journal-title":"Journal of the National Cancer Institute","ISSN":"https:\/\/id.crossref.org\/issn\/0027-8874","issn-type":"print"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.leu.2401723","article-title":"Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia","volume":"14","author":"McLeod HL","year":"2000","journal-title":"Leukemia","ISSN":"https:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/bjmbr\/v37n5\/5258.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T20:37:53Z","timestamp":1586205473000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2004000500004&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0100-879X2004000500004"],"URL":"https:\/\/doi.org\/10.1590\/s0100-879x2004000500004","relation":{},"ISSN":["0100-879X"],"issn-type":[{"value":"0100-879X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}